Robeco Institutional Asset Management B.V.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1418773
ROTTERDAM, P7
Position in NBIX
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$11,595,359
-$4,468,448 QoQ
Shares Held
88,017
-22.3% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 39.95478146267198.ToString("F0")%
Shared 0.ToString("F0")%
None 60.04521853732802.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Robeco Institutional Asset Management B.V. holds $377,171,810 across 14 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
17,177,882 | $237,913,665 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
127,902 | $75,843,327 | |
| 3 | VTRS |
Viatris Inc
|
1,908,453 | $25,783,200 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
88,017 | $11,595,359 | |
| 5 | ALKS |
Alkermes plc.
|
220,521 | $7,797,622 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
174,412 | $4,173,679 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
128,940 | $3,930,091 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
158,096 | $3,572,969 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,595,359 | 88,017 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $16,063,807 | 113,261 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $3,956,610 | 28,185 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $1,897,667 | 15,098 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $1,793,932 | 16,220 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $1,997,541 | 14,634 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $44,622,632 | 387,282 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $45,979,164 | 333,981 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $42,786,232 | 310,225 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $23,413,620 | 177,699 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $17,332,537 | 154,067 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $14,631,870 | 155,163 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $16,442,075 | 162,439 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $22,479,085 | 188,204 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $6,837,587 | 64,378 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $860,748 | 8,830 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $57,187 | 610 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $293,666 | 3,448 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $324,367 | 3,382 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $329,136 | 3,382 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $328,899 | 3,382 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $392,122 | 4,091 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $393,390 | 4,091 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $15,494 | 127 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $290,461 | 3,356 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||